open access

Vol 1, No 6 (2012)
Review articles (submitted)
Published online: 2013-03-11
Get Citation

Chronic kidney disease in patients with type 2 diabetes mellitus

Agata Kujawa-Szewieczek, Grzegorz Piecha, Andrzej Więcek
Diabetologia Kliniczna 2012;1(6):223-232.

open access

Vol 1, No 6 (2012)
Review articles (submitted)
Published online: 2013-03-11

Abstract

In the whole world there is an increasing number of patients with diabetes mellitus. As a consequence chronic diabetic kidney disease, which develops in 15-40% of diabetics, becomes more prevalent. Currently diabetic kidney disease is the most frequent cause for the necessity of renal replacement therapy. Both diabetes and chronic kidney disease increase the risk of cardiovascular complications and death. Diabetic kidney disease is characterized by albuminuria (and proteinuria at later stages) and/or decreased glomerular filtration rate. Yearly screening (urinary albumin excretion and eGFR) is recommended to identify kidney disease in patients with diabetes. Prevention and treatment of diabetic kidney disease is based mainly on optimal serum glucose and blood pressure control. In type 2 diabetics with impaired kidney function oral drugs lowering serum glucose have limited use. Most of them are excreted in urine and the risk for hypoglycemia increases. In the recently introduced incretin drug linagliptin is an interesting alternative. This dipeptydilopeptidase-4 inhibitor is excreted in bile and its metabolism and effects are not changed in patients with impaired kidney function.

Abstract

In the whole world there is an increasing number of patients with diabetes mellitus. As a consequence chronic diabetic kidney disease, which develops in 15-40% of diabetics, becomes more prevalent. Currently diabetic kidney disease is the most frequent cause for the necessity of renal replacement therapy. Both diabetes and chronic kidney disease increase the risk of cardiovascular complications and death. Diabetic kidney disease is characterized by albuminuria (and proteinuria at later stages) and/or decreased glomerular filtration rate. Yearly screening (urinary albumin excretion and eGFR) is recommended to identify kidney disease in patients with diabetes. Prevention and treatment of diabetic kidney disease is based mainly on optimal serum glucose and blood pressure control. In type 2 diabetics with impaired kidney function oral drugs lowering serum glucose have limited use. Most of them are excreted in urine and the risk for hypoglycemia increases. In the recently introduced incretin drug linagliptin is an interesting alternative. This dipeptydilopeptidase-4 inhibitor is excreted in bile and its metabolism and effects are not changed in patients with impaired kidney function.
Get Citation

Keywords

diabetes; chronic kidney disease; albuminuria; hyperglycaemia; dipeptydilopeptidase-4 inhibitors

About this article
Title

Chronic kidney disease in patients with type 2 diabetes mellitus

Journal

Clinical Diabetology

Issue

Vol 1, No 6 (2012)

Pages

223-232

Published online

2013-03-11

Bibliographic record

Diabetologia Kliniczna 2012;1(6):223-232.

Keywords

diabetes
chronic kidney disease
albuminuria
hyperglycaemia
dipeptydilopeptidase-4 inhibitors

Authors

Agata Kujawa-Szewieczek
Grzegorz Piecha
Andrzej Więcek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Diabetologia Kliniczna dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl